MedTrace Logo

Hypersensitivity and Color Changes of Bleached Teeth Using Different Remineralizing Agents

NCT04875000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-06-28

No results posted yet for this study

Summary

The aim of this in vivo study is to evaluate the post-bleaching enamel hypersensitivity and the possible color changes following the application of arginine and nano-hydroxyapatite remineralizing solutions after enamel bleaching using an in-office chemical bleaching agent. A commercial Fluoride remineralizing and desensitizing agent will be used as the control group. Following bleaching of the anterior teeth and then the application of the different tested remineralizing agents; the patients will be assessed for post-bleaching hypersensitivity using the visual analogue scale (VAS) to describe the severity of the hypersensitivity from mild to moderate to severe. On the other hand, the baseline shade and post-bleaching color changes will be evaluated using a shade guide. The data will be collected and tabulated then the statistical analysis will be performed.

The null hypothesis is that the different tested remineralizing agents will have a similar effect on the post-bleaching teeth hypersensitivity \& the color changes of the bleached teeth.

Conditions

  • Tooth Hypersensitivity

Interventions

OTHER

Remineralizing agent I application

Application of UltraEZ remineralizing agent to the bleached teeth

OTHER

Remineralizing agent II application

Application of 2.5% arginine solution to the bleached teeth

OTHER

Remineralizing agent III application

Application of 2.5% nano-hydroxyapatite solution to the bleached teeth

Sponsors & Collaborators

  • National Research Centre, Egypt

    lead OTHER

Principal Investigators

  • Lamiaa M Moharam, Ass. Prof · National Research Centre, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-20
Primary Completion
2021-06-20
Completion
2021-06-20

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04875000 on ClinicalTrials.gov